{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260407618433/en/Acadia-Pharmaceuticals-Announces-DAYBUE%C2%AE-STIX-trofinetide-is-Now-Broadly-Available-in-the-United-States-for-the-Treatment-of-Rett-Syndrome", "message": "News view counter 651055 successfully enlarged"}